| Catalog Number |
PR6066495 |
| CAS |
6066-49-5 |
| Structure |  |
| Description |
Butylphthalide has been used in trials studying the prevention of Restenosis. |
| Synonyms |
3-n-Butylphthalide |
| IUPAC Name |
3-butyl-3H-2-benzofuran-1-one |
| Molecular Weight |
190.24 |
| Molecular Formula |
C12H14O2 |
| InChI |
HJXMNVQARNZTEE-UHFFFAOYSA-N |
| InChI Key |
InChI=1S/C12H14O2/c1-2-3-8-11-9-6-4-5-7-10(9)12(13)14-11/h4-7,11H,2-3,8H2,1H3 |
| Drug Categories |
Antiplatelet agents; Central Nervous System Agents; Compounds used in a research, industrial, or household setting; Drugs, Chinese Herbal; Hematologic Agents; Heterocyclic Compounds, Fused-Ring; Neuroprotective Agents; Plant Extracts; Protective Agents |
| Drug Interactions |
Abciximab-The risk or severity of bleeding can be increased when Butylphthalide is combined with Abciximab.
Abrocitinib-The risk or severity of bleeding and thrombocytopenia can be increased when Butylphthalide is combined with Abrocitinib.
Aceclofenac-The risk or severity of bleeding can be increased when Aceclofenac is combined with Butylphthalide.
Acemetacin-The risk or severity of bleeding can be increased when Acemetacin is combined with Butylphthalide.
Acenocoumarol-The risk or severity of bleeding can be increased when Butylphthalide is combined with Acenocoumarol. |
| Isomeric SMILES |
CCCCC1C2=CC=CC=C2C(=O)O1 |
| Type |
Small Molecule |
| Therapeutic Category |
Cardiovascular |
It should be noted that our service is only used for research, not for clinical use.
